There are currently 8 active clinical trials seeking participants for Dry Eye Syndromes research studies. The states with the highest number of trials for Autism participants are California, Texas, Missouri and Massachusetts.
Prospective Study to Validate the Imaging Biomarker for NCP (R33)
NCT05653921
Recruiting
The aim of this study is establish the reliability and clinical utility of microneuromas as identified via in vivo confocal microscopy as the diagnostic biomarker for NCP.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/09/2024
Locations: Tufts Medical Center, Boston, Massachusetts +1 locations
Conditions: Dry Eye Syndromes, Corneal Disease
Register for Updates
Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects With Dry Eye Disease
NCT05945069
Recruiting
To demonstrate that DMSt + RF improves eye blink quality in subjects with dry eye disease
Gender:
All
Ages:
22 years and above
Trial Updated:
01/21/2024
Locations: Manhattan Face and Eye Cosmetic and Orbital Surgery, New York, New York
Conditions: Eyelid Diseases, Eyelid Movement Disorders, Dry Eye, Dry Eye Syndromes, Skin Laxity
Register for Updates
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922
Recruiting
This study will evaluate the safety, tolerability and efficacy of IC265 compared to vehicle in participants with signs and symptoms dry eye disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/20/2023
Locations: Iacta Selected Site, Andover, Massachusetts
Conditions: Dry Eye Syndromes
Register for Updates
Clinical Applications of Advanced Ophthalmic Imaging
NCT03135327
Recruiting
The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medica... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
09/12/2023
Locations: Bascom Palmer Eye Institute, Miami, Florida
Conditions: Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy, Presbyopia, Myopia, Dementia
Register for Updates
A Usability Study of External Neuromodulation With iTEAR100 Generation 2
NCT05304650
Recruiting
A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/30/2022
Locations: Olympic Ophthalmics, Issaquah, Washington
Conditions: Dry Eye Syndromes
Register for Updates
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients With Dry Eye
NCT05201170
Recruiting
This is a multi-center, double-masked, randomized, vehicle-controlled study testing PL9643, an opthalmic solution to determine if safe and efficacious for dry eye patients. After a 2-week run-in period, patients will be randomized equally to the PL9643 opthalmic solution or vehicle opthalmic solution administered bilaterally three times a day for 12 weeks. A Data Monitoring Committee will be engaged to review interim data.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/08/2022
Locations: Palatin Clinical Site #9, Newport Beach, California +9 locations
Conditions: Dry Eye, Dry Eye Syndromes
Register for Updates
Optimization of the Ocular Surface Prior to Cataract Surgery Using PROKERA
NCT05148507
Recruiting
The purpose of the study is to assess whether PROKERA can sufficiently stabilize the ocular surface prior to cataract surgery and improve post operative outcomes patients with moderate to severe dry disease.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
11/25/2021
Locations: Grin Eye Care, Olathe, Kansas
Conditions: Cataract, Dry Eye Syndromes, Cataract Senile, Dry Eye
Register for Updates
Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL
NCT04863742
Recruiting
This is a prospective, open-label, single-center, randomized, head-to-head, investigator-sponsored clinical study. It aims to investigate the vision recovery and patient comfort in borderline/mild dry eye disease patients undergoing FLACS with Premium PCIOL (i.e., Panoptix, Toric IOL (spherical/multifocal), ReStor, Symfony), receiving a 0.4mg dexamethasone intracanalicular insert when compared to patients receiving standard of care prednisolone acetate 1%.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/26/2021
Locations: SightMD, LIASC, Brentwood, New York
Conditions: Dry Eye Syndromes
Register for Updates